Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Central mechanisms of glucocorticoid circadian rhythm dysfunction in breast cancer

Award Number: R01CA286651
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2024
PERIOD OF PERFORMANCE END DATE: 06/30/2029

Group Awards By:

View Award Description

Central mechanisms of glucocorticoid circadian rhythm dysfunction in breast cancer - Project Summary Breast cancer is still the most common malignancy in women worldwide. Despite the incredible advances made in the past decades towards eliminating breast cancer, nearly all women with metastatic breast cancer will succumb to the disease. Therefore, we desperately need new and improved approaches towards eliminating breast cancer. The proposed work focuses on a widely documented clinical finding with no known underlying mechanism: blunted circulating glucocorticoid rhythms in patients with breast cancer. Critically, patients with ‘flat’ or ‘blunted’ circadian rhythms in circulating glucocorticoids (e.g., cortisol) report lower quality of life and die from cancer earlier than patients with normal ‘robust’ circadian rhythms. Glucocorticoid rhythms are largely controlled by concerted interactions among the hypothalamus, pituitary, and adrenal glands (i.e., HPA-axis), and act to regulate diverse physiological processes essential for health including immune cell trafficking/polarization, energy mobilization, arousal, and synchronization of peripheral circadian clocks. Our preliminary data demonstrate that preclinical mouse models of breast cancer also exhibit this ‘blunting’ of the glucocorticoid rhythm, and this is accompanied by aberrant activity within hypothalamic neurons that regulate the HPA-axis (i.e., PVNCRH neurons). Additionally, by re-establishing a robust glucocorticoid rhythm via chemogenetic stimulation of these neurons, we were able to significantly impede primary breast cancer growth in mouse models. In the present proposal, we will systematically determine where along HPA-axis dysfunction occurs in response to breast cancer, identify the mechanism(s) driving this dysfunction, and then use orthogonal approaches to manipulate these mechanisms to confer benefits (reduced tumor and metastatic burden, enhanced responses to checkpoint blockade immunotherapy) in mouse models of breast cancer. These studies represent a significant step forward in our understanding of how malignant processes influence the host, and how host responses dictate cancer progression and therapeutic efficacy. These data will further inform the design of novel therapeutic approaches towards eliminating breast cancer by targeting the HPA-axis.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $1,382,486 )
2026	2026	COLD SPRING HARBOR LABORATORY	1 BUNGTOWN RD	COLD SPG HBR	NY	11724	SUFFOLK	USA	Cancer Biology Research	001	3	6/26/2026	EXTENSION WITH OR WITHOUT FUNDS	$1,382,486
2026	2025	COLD SPRING HARBOR LABORATORY	1 BUNGTOWN RD	COLD SPG HBR	NY	11724	SUFFOLK	USA	Cancer Biology Research	000	2	6/16/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,382,486

Issue Date FY: 2025 ( Subtotal = $460,829 )
2025	2025	COLD SPRING HARBOR LABORATORY	1 BUNGTOWN RD	COLD SPG HBR	NY	11724	SUFFOLK	USA	Cancer Biology Research	000	2	6/3/2025	NON-COMPETING CONTINUATION	$460,829
														Subtotal = $460,829

Issue Date FY: 2024 ( Subtotal = $456,048 )
2024	2024	COLD SPRING HARBOR LABORATORY	1 BUNGTOWN RD	COLD SPG HBR	NY	11724	SUFFOLK	USA	Cancer Biology Research	000	1	6/27/2024	NEW	$456,048
														Subtotal = $456,048

Grand Total All Awards = $2,299,363

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Central mechanisms of glucocorticoid circadian rhythm dysfunction in breast cancer

Award Number: R01CA286651

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2024

PERIOD OF PERFORMANCE END DATE: 06/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer